Analysis of false-negative human immunodeficiency virus rapid tests performed on oral fluid in 3 international clinical research studies

Clinical Infectious Diseases

Volumn 64, Issue 12, 2017, Pages 1663-1669

  Curlin, Marcel E ^a,b,d   Gvetadze, Roman ^b   Leelawiwat, Wanna ^a   Martin, Michael ^a,b   Rose, Charles ^b   Niska, Richard W ^b   Segolodi, Tebogo M ^b   Choopanya, Kachit ^c   Tongtoyai, Jaray ^a   Holtz, Timothy H ^a,b   Samandari, Taraz ^b   Mcnicholl, Janet M ^b  

^a Centers for Disease Control CDC Thailand Field Station   (Thailand)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Bangkok Tenofovir Study Group   (Thailand)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

HIV; immunosorbent techniques; oral fluid; point of care testing.; serodiagnosis

Indexed keywords

EMTRICITABINE; PLACEBO; TENOFOVIR DISOPROXIL; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ANTIRETROVIRAL THERAPY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME IMMUNOASSAY; FALSE NEGATIVE RESULT; FEMALE; FLUID INTAKE; HIV RAPID TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID AMPLIFICATION; OBSERVATIONAL STUDY; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TURNAROUND TIME; VIRUS LOAD; BLOOD; BOTSWANA; CLINICAL STUDY; DIAGNOSTIC KIT; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNOLOGY; ISOLATION AND PURIFICATION; POINT OF CARE SYSTEM; POLYMERASE CHAIN REACTION; PRE-EXPOSURE PROPHYLAXIS; REGRESSION ANALYSIS; SALIVA; SERODIAGNOSIS; THAILAND; VIROLOGY;

ADULT; AIDS SERODIAGNOSIS; BOTSWANA; CLINICAL STUDIES AS TOPIC; FALSE NEGATIVE REACTIONS; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; POINT-OF-CARE SYSTEMS; POLYMERASE CHAIN REACTION; PRE-EXPOSURE PROPHYLAXIS; REAGENT KITS, DIAGNOSTIC; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SALIVA; SENSITIVITY AND SPECIFICITY; THAILAND; VIRAL LOAD;

EID: 85021108060     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix228     Document Type: Article

References (32)

1. Gallo D, George JR, Fitchen JH, Goldstein AS, Hindahl MS. Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. OraSure HIV Clinical Trials Group. JAMA 1997; 277: 254-8
2. Carballo-Dieguez A, Frasca T, Balan I, Ibitoye M, Dolezal C. Use of a rapid HIV home test prevents HIV exposure in a high risk sample of men who have sex with men. AIDS Behav 2012; 16: 1753-60
3. Ibitoye M, Frasca T, Giguere R, Carballo-Dieguez A. Home testing past, present and future: lessons learned and implications for HIV home tests. AIDS Behav 2014; 18: 933-49
4. Oraquick Advance HIV-1/2 Rapid Antibody Test Package Insert. Available at: https://www.fda.gov/downloads/BiologicsBloodVaccines/ucm091917.pdf. Accessed 3 April 2017
5. OraSure Technologies I. Oraquick HIV1/2 Rapid HIV1/2 Antibody Test-for outside USA use only. Available at: http://www.pathwaybiomed.com/products-OraQuick.html. Accessed 3 April 2017
6. Pavie J, Rachline A, Loze B, et al. Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS One 2010; 5: e11581
7. Stekler JD, O'Neal JD, Lane A, et al. Relative accuracy of serum, whole blood, and oral fluid HIV tests among Seattle men who have sex with men. J Clin Virol 2013; 58(suppl 1): e119-22
8. O'Connell RJ, Merritt TM, Malia JA, et al. Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol 2003; 41: 2153-5
9. Delaney KP, Branson BM, Uniyal A, et al. Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS 2006; 20: 1655-60
10. Pilcher CD, Louie B, Facente S, et al. Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco. PLoS One 2013; 8: e80629
11. Holguin A, Gutierrez M, Portocarrero N, Rivas P, Baquero M. Performance of OraQuick advance rapid HIV-1/2 antibody test for detection of antibodies in oral fluid and serum/plasma in HIV-1+ subjects carrying different HIV-1 subtypes and recombinant variants. J Clin Virol 2009; 45: 150-2
12. Pant Pai N, Joshi R, Dogra S, et al. Evaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India. PLoS One 2007; 2: e367
13. Suntharasamai P, Martin M, Choopanya K, et al. Assessment of Oral Fluid HIV Test performance in an HIV pre-exposure prophylaxis trial in Bangkok, Thailand. PLoS One 2015; 10: e0145859
14. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. TDF2 Study Group. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012; 367: 423-34
15. Choopanya K, Martin M, Suntharasamai P, et al. Bangkok Tenofovir Study Group. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013; 381: 2083-90
16. Van Griensven F, Thienkrua W, McNicholl J, et al. Evidence of an explosive epidemic of HIV infection in a cohort of men who have sex with men in Thailand. AIDS 2013; 27: 825-32
17. Leelawiwat W, Rutvisuttinunt W, Arroyo M, et al. Increasing HIV-1 molecular complexity among men who have sex with men in Bangkok. AIDS Res Hum Retroviruses 2015; 31: 393-400
18. Ananworanich J, Schuetz A, Vandergeeten C, et al. RV254/SEARCH 010 Study Group. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One 2012; 7: e33948
19. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003; 157: 940-3
20. Hardin JW, Hilbe JM. Generalized estimating equations. Boca Raton, FL: Chapman & Hall/CRC 2003
21. Wiegand RE, Rose CE, Karon JM. Comparison of models for analyzing twogroup, cross-sectional data with a Gaussian outcome subject to a detection limit. Stat Methods Med Res 2016; 25: 2733-49
22. Thiebaut R, Jacqmin-Gadda H. Mixed models for longitudinal left-censored repeated measures. Comput Methods Programs Biomed 2004; 74: 255-60
23. Zachary D, Mwenge L, Muyoyeta M, et al. Field comparison of OraQuick ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia. BMC Infect Dis 2012; 12: 183
24. Debattista J, Bryson G, Roudenko N, et al. Pilot of non-invasive (oral fluid) testing for HIV within a clinical setting. Sex Health 2007; 4: 105-9
25. Scott LE, Noble LD, Langeveldt M, Jentsch U, Francois Venter WD, Stevens W. Can oral fluid testing be used to replace blood-based HIV rapid testing to improve access to diagnosis in South Africa? J Acquir Immune Defic Syndr 2009; 51: 646-8; author reply 648-9
26. Luo W, Masciotra S, Delaney KP, et al. Comparison of HIV oral fluid and plasma antibody results during early infection in a longitudinal Nigerian cohort. J Clin Virol 2013; 58(suppl 1): e113-8
27. Granade TC, Phillips SK, Parekh B, et al. Detection of antibodies to human immunodeficiency virus type 1 in oral fluids: a large-scale evaluation of immunoassay performance. Clin Diagn Lab Immunol 1998; 5: 171-5
28. Soto-Ramirez LE, Hernandez-Gomez L, Sifuentes-Osornio J, et al. Detection of specific antibodies in gingival crevicular transudate by enzyme-linked immunosorbent assay for diagnosis of human immunodeficiency virus type 1 infection. J Clin Microbiol 1992; 30: 2780-3
29. Merchant M, Wright M, Kabat W, Yogev R. Long-term highly suppressed HIVinfected children and adolescents with negative rapid HIV tests due to significant antibody loss. J Clin Virol 2014; 59: 172-6
30. Zelin J, Garrett N, Saunders J, et al. North East London Sexual Health Network Research Consortium. An evaluation of the performance of OraQuick ADVANCE Rapid HIV-1/2 Test in a high-risk population attending genitourinary medicine clinics in East London, UK. Int J STD AIDS 2008; 19: 665-7
31. Ng OT, Chow AL, Lee VJ, et al. Accuracy and user-acceptability of HIV self-testing using an oral fluid-based HIV rapid test. PLoS One 2012; 7: e45168
32. Facente SN, Dowling T, Vittinghoff E, Sykes DL, Colfax GN. False positive rate of rapid oral fluid HIV tests increases as kits near expiration date. PLoS One 2009; 4: e8217